In this study, researchers aimed to investigate whether discontinuing premedications after 2 doses of paclitaxel is safe and feasible in some breast cancer patients.

Researchers investigated the link between diabetes status and cancer risk over 10 years among a diverse cohort of Hispanic and Latino adults.

This review of studies highlights a call for radiation oncology frameworks that better localize, contour, and spare the ...

Beqalzi (sonrotoclax) is the first BCL2 inhibitor indicated for MCL patients who have progressed after at least 2 lines of therapy, including a BTK inhibitor.

Increasing the representation of sexual and gender minorities in cancer clinical trials is vital to develop evidence-based, ...

Researchers evaluated whether daraxonrasib, an oral RAS(ON) multiselective inhibitor that targets guanosine triphosphate-bound mutant and wild-type RAS, would be safe and effective in patients with ...

On March 20, the FDA approved Opdivo for adult and pediatric patients (aged 12 years and older) with previously untreated ...

Investigators sought to determine whether hiring management consultants resulted in meaningful changes in finances, operations, or quality of care at nonprofit hospitals in the US.

Financial concerns, inconsistent preventive care, and limited access to credible information are influencing health decisions across life stages ...

Clinical trial recruitment is currently ongoing for lung, breast, pancreatic, colorectal, and uterine cancers, the deadliest ...

Investigators compared outcomes up to 15 years post-diagnosis across 6 racial/ethnic groups to identify disparities in survival.

Marty Makary, who was a surgical oncologist and professor at John Hopkins University has quit his job as FDA Commissioner.